Tag: Nestle
Nestlé to acquire core brands of vitamins manufacturer Bountiful for $5.7bn
Nestlé has signed a deal worth $5.75 billion with KKR to acquire core brands of Bountiful, a US manufacturer of vitamins and nutritional supplements. Included ... Read More
Nestlé unveils vegan KitKat chocolate – KitKat V
Swiss food and beverage giant Nestlé is set to launch a vegan KitKat to be branded as KitKat V, this year across various countries. KitKat ... Read More
Nestlé to sell Nestlé Waters North America for $4.3bn to One Rock and Metropoulos
Nestlé has signed a deal worth $4.3 billion to offload Nestlé Waters North America brands to One Rock Capital Partners in partnership with Metropoulos & ... Read More
Nestlé to sell Yinlu peanut milk and canned rice porridge businesses in China
Nestlé has signed a deal to divest its Yinlu peanut milk and canned rice porridge businesses in China to Food Wise for an undisclosed price. ... Read More
Nestlé acquires US meal delivery service Freshly in deal worth up to $1.5bn
Nestlé acquisition of Freshly : Swiss food and beverage giant Nestlé, through its US subsidiary, has acquired Freshly, an American provider of fresh-prepared meal delivery ... Read More
Nestlé to fully own Aimmune Therapeutics through $2bn deal
Nestlé will take full ownership of Aimmune Therapeutics, the developer of FDA approved peanut allergy drug Palforzia, by acquiring the remaining stake of 74.4% in ... Read More
Gerber Organic BabyPops puffed corn and oat snack launched for crawlers
Gerber Products, a childhood nutrition company, which is a part of Nestlé, has launched Gerber Organic BabyPops, a new puffed corn and oat snack, to ... Read More
Nestlé Nespresso to expand Romont production center with $170m investment
Nestlé Nespresso (Nespresso) will invest CHF160 million ($170.28 million) to expand its Romont production center in Switzerland to address the growing consumer demand for its ... Read More
Nestlé increases stake in Aimmune Therapeutics after Palforzia FDA approval
Aimmune Therapeutics, which has recently bagged approval from the US Food and Drug Administration (FDA) for its peanut allergy drug PALFORZIA (formerly AR101), has secured ... Read More
Allergan to sell brazikumab to AstraZeneca and Zenpep to Nestle
Allergan has agreed to sell IL-23 inhibitor brazikumab to AstraZeneca and gastrointestinal medication Zenpep (pancrelipase) to Nestle in separate agreements, as per the latest pharma ... Read More
